-
1 Comment
SuperSonic Imagine SA is currently in a long term uptrend where the price is trading 5.9% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.1.
Finally, its free cash flow grew by 36.7% to $-3M since the same quarter in the previous year.
Based on the above factors, SuperSonic Imagine SA gets an overall score of 3/5.
Industry | Medical Devices |
---|---|
Sector | Healthcare |
ISIN | None |
CurrencyCode | EUR |
Exchange | F |
Beta | 0.1 |
---|---|
Target Price | None |
PE Ratio | None |
Market Cap | 35M |
Dividend Yield | None |
SuperSonic Imagine SA operates as a medical technology company. The company designs, develops, and markets Aixplorer, an ultrasound system that renders images with exceptional definition, contrast, and resolution; and Aixplorer MACH ultrasound machines. It has developed a technology that offers practitioners and patients a breakthrough in the diagnosis and follow up of breast, prostate, and thyroid cancers, as well as liver diseases. The company serves China, the United States, France, Asia, and the Europe, Middle East, and Africa. The company was founded in 2005 and is headquartered in Aix-en-Provence, France. SuperSonic Imagine SA is a subsidiary of Hologic Hub Ltd.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 7SO.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024